CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 137 filers reported holding CHINA BIOLOGIC PRODS INC in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $301,000 | -41.8% | 2,665 | -48.3% | 0.02% | -48.6% |
| Q1 2017 | $517,000 | +2250.0% | 5,159 | +2479.5% | 0.04% | +1750.0% |
| Q4 2016 | $22,000 | -45.0% | 200 | -47.1% | 0.00% | 0.0% |
| Q2 2016 | $40,000 | +73.9% | 378 | +89.0% | 0.00% | +100.0% |
| Q2 2015 | $23,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WARBURG PINCUS LLC | 8,344,200 | $960,918,000 | 7.67% |
| RUDMAN ERROL M | 130,201 | $14,994,000 | 5.06% |
| Ativo Capital Management LLC | 59,101 | $7,258,000 | 2.56% |
| Kylin Management | 188,226 | $21,676,000 | 2.36% |
| Monashee Investment Management LLC | 40,000 | $4,606,000 | 2.17% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 62,866 | $7,240,000 | 1.91% |
| Cormorant Asset Management, LP | 111,500 | $12,840,000 | 1.71% |
| OBERWEIS ASSET MANAGEMENT INC/ | 53,500 | $6,161,000 | 1.63% |
| Perceptive Advisors | 147,604 | $16,998,000 | 1.02% |
| Granite Point Capital Management, L.P. | 29,160 | $3,358,000 | 0.98% |